Second malignant neoplasms in patients with non hodgkin's lymphoma

Michael Lishner, Joyce Slingerland, Joseph Barr, Tony Panzarella, Pam Degendorfer, Simon Sutcliffe

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

A retrospective review of the records of 3886 patients with non-Hodgkin's lymphoma registered at the Princess Margaret Hospital between 1970 and 1985 was undertaken to determine the incidence of second malignant tumours. Three thousand and twenty-one patients with a minimum documented follow-up of 6 months from referral were identified for analysis. The overall observed/expected ratio for all cancers in patients with malignant lymphoma was 1, suggesting no increased risk of developing a second malignant neoplasm compared to the general population. When the data were analyzed independently for each tumour site, statistically significant increased risk of developing acute non lymphocytic leukemia (ANLL) (p < 0.001) and carcinoma of the tongue (p < 0.05) were found. An increased risk of lung cancer following lymphoma was detected but was not statistically significant. Survival following diagnosis of ANLL and lung cancer was similar and significantly shorter than that following the diagnosis of other second malignancies. The risk of developing a second primary cancer was significantly related to increasing patient age.

Original languageEnglish (US)
Pages (from-to)169-179
Number of pages11
JournalHematological Oncology
Volume9
Issue number3
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Keywords

  • Non‐Hodgkin's lymphoma
  • Second malignancies

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Second malignant neoplasms in patients with non hodgkin's lymphoma'. Together they form a unique fingerprint.

  • Cite this

    Lishner, M., Slingerland, J., Barr, J., Panzarella, T., Degendorfer, P., & Sutcliffe, S. (1991). Second malignant neoplasms in patients with non hodgkin's lymphoma. Hematological Oncology, 9(3), 169-179. https://doi.org/10.1002/hon.2900090308